Adalat Retard Tablets / Sustained Release

Nifedipine
20mg
BAYER SCHERING PHARMA AG
Pack size 30's Glass Bottle
Dispensing mode POM
Source GERMANY
AgentAL ITTIHAD DRUG STORE
Retail Price 45.00 AED

Indications

Adalat Retard Tablets / Sustained Release is used for: Hypertension, Angina pectoris, Raynaud's syndrome, Stroke prevention

Adult Dose

Oral Hypertension Adult: Immediate-release: Initially, 5 mg tid. Maintenance: 10-20 mg tid. Extended-release: Initially, 10-40 mg bid, or 20-90 mg once daily. Angina pectoris Adult: Immediate-release: Initially, 10 mg tid. Maintenance: 10-20 mg tid. Extended-release: 10-40 mg bid or 30-60 mg once daily. Raynaud's syndrome Adult: Immediate-release: 5-20 mg tid. Elderly: Dose reduction may be necessary. Hepatic impairment: Dose reduction may be necessary.

Child Dose

Renal Dose

Administration

Immediate-release: May be taken with or without food. Avoid grapefruit juice. Retard, GITS & OROS: May be taken with or without food. Avoid grapefruit juice. Swallow whole, do not chew/crush.

Contra Indications

Acute MI, cardiogenic shock, acute unstable angina, treatment of anginal attack in chronic stable angina.

Precautions

Patients w/ hypotension, poor cardiac reserve, heart failure, severe aortic stenosis, DM, underlying severe GI narrowing (extended-release tab). Avoid abrupt withdrawal as it may casue rebound angina. Hepatic impairment. Elderly. Pregnancy and lactation. Patient Counselling Discontinue if ischaemic pain follows after admin. Monitoring Parameters Monitor BP, heart rate. Lactation: Drug is distributed into breast milk; manufacturer suggests discontinuing drug or refraining from nursing (however, American Academy of Pediatrics states that drug is safe for nursing)

Pregnancy-Lactation

Interactions

Enhanced antihypertensive effects w/ other antihypertensives, aldesleukin, and antipsychotics. Concomitant use w/ fentanyl during surgery caused severe hypotension. May modify insulin and glucose responses. Attenuation of tachycardic effect when used w/ benazerpril. Prothrombin time may be increased w/ coumarin anticoagulants. Increased serum levels w/ CYP3A4 inhibitors (e.g. azole antifungals, cimetidine, erythromycin, HIV-protease inhibitors, nefazodone, fluoxetine, quinupristin/dalfopristin). Potentially Fatal: Decreased bioavailability and efficacy w/ strong CYP3A4 inducers (e.g. rifampicin, phenytoin, carbamazepine).

Adverse Effects

Side effects of Nifedipine : >10% Peripheral edema (10-30%), Dizziness (23-27%), Flushing (23-27%), Headache (10-23%), Heartburn (11%), Nausea (11%) 1-10% Muscle cramps (8%), Mood change (7%), Nervousness (7%), Cough (6%), Dyspnea (6%), Palpitations (6%), Wheezing (6%), Hypotension, transient (5%), Urticaria (2%), Pruritus (2%), Constipation (<2%), Chest pain (<2%) Frequency Not Defined Gingival hyperplasia, Agranulocytosis, Erectile dysfunction

Mechanism of Action

Nifedipine prevents Ca ion from entering the slow channels of cardiac and smooth muscles during depolarisation, producing peripheral and coronary vasodilatation. It reduces afterload, peripheral resistance and BP; increases coronary blood flow and causes reflex tachycardia. It has little or no effect on cardiac conduction and rarely has negative inotropic activity.

Note

Adalat Retard 20mg Tablets / Sustained Release manufactured by BAYER SCHERING PHARMA AG. Its generic name is Nifedipine. Adalat Retard is availble in United Arab Emirates. Farmaco UAE drug index information on Adalat Retard Tablets / Sustained Release is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Nifedipine :

Capsules (Hard Gelatin)
Nifecard 10mg
Dar Al Dawa Development & Investment Co. Ltd.
Capsules (Hard Gelatin)
Novo-Nifedin 10mg
NOVOPHARM LTD.
Capsules (Hard Gelatin)
Epilat 10mg
Egyptian International Pharmaceutical Industries Co. (E.I.P.I.Co.)
Capsules (Hard Gelatin)
CORACTEN Spansules 20mg
WULFING PHARMA GmbH
Capsules (Hard Gelatin)
CORACTEN Spansules 20mg
WULFING PHARMA GmbH